ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 127 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $201 | +737.5% | 29,424 | +1155.8% | 0.00% | – |
| Q2 2023 | $24 | -97.6% | 2,343 | -98.1% | 0.00% | -100.0% |
| Q1 2023 | $1,016 | +101500.0% | 125,627 | +134982.8% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 93 | -90.4% | 0.00% | – |
| Q3 2022 | $15,000 | -93.0% | 972 | -92.2% | 0.00% | – |
| Q1 2022 | $215,000 | -38.7% | 12,482 | -48.4% | 0.00% | – |
| Q4 2021 | $351,000 | +380.8% | 24,199 | +470.3% | 0.00% | – |
| Q3 2021 | $73,000 | -7.6% | 4,243 | -6.5% | 0.00% | – |
| Q2 2021 | $79,000 | -77.6% | 4,539 | -67.5% | 0.00% | -100.0% |
| Q1 2021 | $352,000 | +1308.0% | 13,973 | +258.6% | 0.00% | – |
| Q4 2020 | $25,000 | +212.5% | 3,897 | +21.9% | 0.00% | – |
| Q3 2020 | $8,000 | – | 3,196 | +520.6% | 0.00% | – |
| Q2 2020 | $0 | – | 515 | +104.4% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 252 | -86.8% | 0.00% | – |
| Q3 2019 | $2,000 | -80.0% | 1,914 | -58.8% | 0.00% | – |
| Q2 2019 | $10,000 | -16.7% | 4,648 | +131.2% | 0.00% | – |
| Q1 2019 | $12,000 | +500.0% | 2,010 | +443.2% | 0.00% | – |
| Q4 2018 | $2,000 | – | 370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |